Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

Dexpanthenol improves hair growth in male baldness.

DK peptides can reduce hair loss by inhibiting the 5α-reductase enzyme and have antioxidant effects.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

Methotrexate plus prednisolone had the fewest serious side effects.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

New compounds may help treat prostate issues without affecting androgen receptors.

Knowing about potential side effects can make them more likely to happen.

WYE-130600 may cause skin thickening and irritation.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Control variability makes it hard to confirm low-dose endocrine effects.

A new method was developed to accurately measure enzyme activity related to prostate health.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Dutasteride helps slow hair loss and boosts hair growth.

DNCB is more effective than betamethasone for hair regrowth but has more side effects.

Experts agree on guidelines for safely using low-dose oral minoxidil to treat hair loss.

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Bicalutamide added no extra benefit over minoxidil alone for female-pattern hair loss.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Some prostate cancers have gene changes that may affect treatment with certain drugs.